Human SNP ID | rs2833197 |
---|---|
Human chromosome | chr21 |
Human SNP position | 31034797 |
Pig chromosome | chr13 |
Pig SNP position | 204997770 |
PubMed ID | 21844884 |
---|---|
Journal | Pharmacogenomics J |
Link | www.ncbi.nlm.nih.gov/pubmed/21844884 |
Study | Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations |
Disease/Trait | Response to platinum-based chemotherapy (cisplatin) |
Initial sample | 176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines |
Replication sample | NA |
Region | 21q22.11 |
Chromosome id | chr21 |
Chromosome position | 31034797 |
Reported gene | intergenic |
Mapped gene | LOC105372774 |
Upstream gene id | |
Downstream gene id | |
SNP gene ids | 105372774 |
Upstream gene distance | |
Downstream gene distance | |
SNP risk allele | rs2833197-? |
SNPs | rs2833197 |
Merged | 0 |
SNP id current | 2833197 |
Context | downstream_gene_variant |
Intergenic | 0 |
Allele frequency | |
P value | 0.000009 |
Pvalue mlog | 5.04575749056067 |
P value text | |
Or beta | |
%95 Ci | |
Platform | NR [~ 3000000] (imputed) |
CNV | N |
Mapped trait | response to cisplatin |
Mapped trait URI | http://purl.obolibrary.org/obo/GO_0072718 |
Study accession | GCST001201 |